middle.news
$2.3 Million Placement Secures Funding for Percheron's AML Trial
9:23am on Tuesday 1st of September, 2026 AEST
•
Biotechnology
Read Story
$2.3 Million Placement Secures Funding for Percheron's AML Trial
9:23am on Tuesday 1st of September, 2026 AEST
Key Points
Institutional placement raises $2.3 million
300 million new shares issued at $0.005 each
Up to 230 million options with $0.01 strike price
Funds to cover AML clinical trial and working capital
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Percheron Therapeutics (ASX:PER)
OPEN ARTICLE